41.   Wolfe, a frequent critic of the FDA, said the action is an example of new and lower standards the agency is now using for drug approvals.

42.   Challenging the perception that the United States delays approvals of new drugs, a study released Tuesday said US drug approvals were faster than in Germany and Japan.